Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II

Bioorganic Chemistry - Tập 58 - Trang 104-116 - 2015
Said A.H. El-Feky1,2, Zakaria K. Abd El-Samii2, Nermine A. Osman2, Jasmine Lashine2, Mohamed A. Kamel3, Hamdy Kh. Thabet4,5
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, PO Box 840, Rafha 91911, Saudi Arabia
2Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
3Department of Pharmacology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
4Department of Chemistry, Faculty of Arts and Science, Northern Border University, PO Box 840, Rafha 91911, Saudi Arabia
5Department of Chemistry, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11284, Egypt

Tài liệu tham khảo

El-Feky, 2014, J. Fluorine Chem., 161, 87, 10.1016/j.jfluchem.2014.02.012 Solomon, 2007, Arch. der Pharm., 340, 352, 10.1002/ardp.200700017 Lima, 2005, Curr. Med. Chem., 12, 23, 10.2174/0929867053363540 Dumeunier, 2013, Synlett, 24, 1150, 10.1055/s-0033-1338433 Zhou, 2014, Bioorg. Chem., 57, 30, 10.1016/j.bioorg.2014.07.011 Tsurumi, 1976, Pharmacol. Jpn., 41, 72 Kees, 1996, J. Med. Chem., 39, 3920, 10.1021/jm960444z Athina, 2004, Bioorg. Med. Chem., 12, 6559, 10.1016/j.bmc.2004.09.016 Singh, 2005, Orient. J. Chem., 16, 315 Ali, 2007, Nat. Prod. Res., 21, 575, 10.1080/14786410701369367 Grosscurt, 1979, J. Agric. Food Chem., 27, 406, 10.1021/jf60222a061 Sridhar, 2012, E-J. Chem., 9, 1810, 10.1155/2012/476989 Kumar Tewari, 2014, Bioorg. Chem., 56, 8, 10.1016/j.bioorg.2014.05.004 Wright, 1964, J. Med. Chem., 7, 10, 10.1021/jm00331a003 Abid, 2005, Bioorg. Med. Chem., 13, 2213, 10.1016/j.bmc.2004.12.050 Batulin, 1968, Farmakol Toksikol, 31, 533 Parmar, 1974, J. Pharm. Sci., 63, 1152, 10.1002/jps.2600630730 Soni, 1987, Res. Commun. Chem. Pathol. Pharmacol., 56, 129 Turan-Zitouni, 2000, Eur. J. Med. Chem., 35, 635, 10.1016/S0223-5234(00)00152-5 Palaska, 1996, Eur. J. Med. Chem., 31, 43, 10.1016/S0223-5234(96)80005-5 Havrylyuk, 2009, Eur. J. Med. Chem., 44, 1396, 10.1016/j.ejmech.2008.09.032 Kumar, 2009, Drug Discov., 4, 154 Ibrahim, 2012, Med. Chem. Res., 21, 4369, 10.1007/s00044-012-9975-3 Elagawany, 2013, Bioorg. Med. Chem. Lett., 23, 2007, 10.1016/j.bmcl.2013.02.027 Pfitzinger, 1886, J. Prakt. Chem., 33, 100, 10.1002/prac.18850330110 Li, 2005, Synlett, 13, 2003 Robinson, 2005, Bioorg. Med. Chem., 13, 4007, 10.1016/j.bmc.2005.03.054 Molecular Operating Environment (MOE 2009.10). C.C.G., Inc., 1010 Sherbrooke West, Suite 910, Montreal, Quebec, Canada H3A 2R7. Winter, 1962, Proc. Soc. Exp. Biol. Med., 111, 544, 10.3181/00379727-111-27849 Ghodsi, 2012, Res. Pharm. Sci., 7, S507 Rainsford, 1978, Agents Act., 8, 587, 10.1007/BF01998888 Jacob, 1965 Wilhelmi, 1972, Pharmacology, 8, 321, 10.1159/000136348 Pauls, 1997, Gastroenterology, 8, 774 Paget, 1964, vol. I Mukherjee, 2013, Drug Discovery Today, 18, 389, 10.1016/j.drudis.2012.11.003 Abdel-Aziz, 2011, Eur. J. Med. Chem., 46, 1648, 10.1016/j.ejmech.2011.02.013